REPORT ID 1236

Asia-Pacific Double Barreled Antibodies Drug Market Report 2017

Publish Date
05-Dec-17
Pages
114
Format
Electronic (PDF)

In this report, the Asia-Pacific Double Barreled Antibodies Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Double Barreled Antibodies Drug for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Double Barreled Antibodies Drug market competition by top manufacturers/players, with Double Barreled Antibodies Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Amgen Inc.
    F. Hoffman La Roche Ltd.
    AbbVie Inc.
    OncoMed Pharmaceuticals, Inc.
    Glenmark Pharmaceuticals Limited
    Xencor, Inc.
    MacroGenics, Inc.
    Aptevo Therapeutics Inc.
    Ligand Pharmaceuticals, Inc.
    Regeneron Pharmaceuticals, Inc.
    Fresenius SE & Co. KGaA
    Merus N.V.

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Removab
    BLINCYTO
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Lung Cancer
    Brain Cancer
    Liver Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Double Barreled Antibodies Drug Market Report 2017
1 Double Barreled Antibodies Drug Overview
    1.1 Product Overview and Scope of Double Barreled Antibodies Drug
    1.2 Classification of Double Barreled Antibodies Drug by Product Category
        1.2.1 Asia-Pacific Double Barreled Antibodies Drug Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Double Barreled Antibodies Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Removab
        1.2.4 BLINCYTO
        1.2.5 Others
    1.3 Asia-Pacific Double Barreled Antibodies Drug Market by Application/End Users
        1.3.1 Asia-Pacific Double Barreled Antibodies Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Lung Cancer
        1.3.3 Brain Cancer
        1.3.4 Liver Cancer
        1.3.5 Others
    1.4 Asia-Pacific Double Barreled Antibodies Drug Market by Region
        1.4.1 Asia-Pacific Double Barreled Antibodies Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Double Barreled Antibodies Drug (2012-2022)
        1.5.1 Asia-Pacific Double Barreled Antibodies Drug Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Double Barreled Antibodies Drug Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Double Barreled Antibodies Drug Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Double Barreled Antibodies Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Double Barreled Antibodies Drug Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Double Barreled Antibodies Drug (Volume and Value) by Type
        2.2.1 Asia-Pacific Double Barreled Antibodies Drug Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Double Barreled Antibodies Drug Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Double Barreled Antibodies Drug (Volume) by Application
    2.4 Asia-Pacific Double Barreled Antibodies Drug (Volume and Value) by Region
        2.4.1 Asia-Pacific Double Barreled Antibodies Drug Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Double Barreled Antibodies Drug Revenue and Market Share by Region (2012-2017)

3 China Double Barreled Antibodies Drug (Volume, Value and Sales Price)
    3.1 China Double Barreled Antibodies Drug Sales and Value (2012-2017)
        3.1.1 China Double Barreled Antibodies Drug Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2017)
        3.1.3 China Double Barreled Antibodies Drug Sales Price Trend (2012-2017)
    3.2 China Double Barreled Antibodies Drug Sales Volume and Market Share by Type
    3.3 China Double Barreled Antibodies Drug Sales Volume and Market Share by Application

4 Japan Double Barreled Antibodies Drug (Volume, Value and Sales Price)
    4.1 Japan Double Barreled Antibodies Drug Sales and Value (2012-2017)
        4.1.1 Japan Double Barreled Antibodies Drug Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Double Barreled Antibodies Drug Sales Price Trend (2012-2017)
    4.2 Japan Double Barreled Antibodies Drug Sales Volume and Market Share by Type
    4.3 Japan Double Barreled Antibodies Drug Sales Volume and Market Share by Application

5 South Korea Double Barreled Antibodies Drug (Volume, Value and Sales Price)
    5.1 South Korea Double Barreled Antibodies Drug Sales and Value (2012-2017)
        5.1.1 South Korea Double Barreled Antibodies Drug Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Double Barreled Antibodies Drug Sales Price Trend (2012-2017)
    5.2 South Korea Double Barreled Antibodies Drug Sales Volume and Market Share by Type
    5.3 South Korea Double Barreled Antibodies Drug Sales Volume and Market Share by Application

6 Taiwan Double Barreled Antibodies Drug (Volume, Value and Sales Price)
    6.1 Taiwan Double Barreled Antibodies Drug Sales and Value (2012-2017)
        6.1.1 Taiwan Double Barreled Antibodies Drug Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Double Barreled Antibodies Drug Sales Price Trend (2012-2017)
    6.2 Taiwan Double Barreled Antibodies Drug Sales Volume and Market Share by Type
    6.3 Taiwan Double Barreled Antibodies Drug Sales Volume and Market Share by Application

7 India Double Barreled Antibodies Drug (Volume, Value and Sales Price)
    7.1 India Double Barreled Antibodies Drug Sales and Value (2012-2017)
        7.1.1 India Double Barreled Antibodies Drug Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2017)
        7.1.3 India Double Barreled Antibodies Drug Sales Price Trend (2012-2017)
    7.2 India Double Barreled Antibodies Drug Sales Volume and Market Share by Type
    7.3 India Double Barreled Antibodies Drug Sales Volume and Market Share by Application

8 Southeast Asia Double Barreled Antibodies Drug (Volume, Value and Sales Price)
    8.1 Southeast Asia Double Barreled Antibodies Drug Sales and Value (2012-2017)
        8.1.1 Southeast Asia Double Barreled Antibodies Drug Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Double Barreled Antibodies Drug Sales Price Trend (2012-2017)
    8.2 Southeast Asia Double Barreled Antibodies Drug Sales Volume and Market Share by Type
    8.3 Southeast Asia Double Barreled Antibodies Drug Sales Volume and Market Share by Application

9 Australia Double Barreled Antibodies Drug (Volume, Value and Sales Price)
    9.1 Australia Double Barreled Antibodies Drug Sales and Value (2012-2017)
        9.1.1 Australia Double Barreled Antibodies Drug Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Double Barreled Antibodies Drug Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Double Barreled Antibodies Drug Sales Price Trend (2012-2017)
    9.2 Australia Double Barreled Antibodies Drug Sales Volume and Market Share by Type
    9.3 Australia Double Barreled Antibodies Drug Sales Volume and Market Share by Application

10 Asia-Pacific Double Barreled Antibodies Drug Players/Suppliers Profiles and Sales Data
    10.1 Amgen Inc.
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Amgen Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 F. Hoffman La Roche Ltd.
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 AbbVie Inc.
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 AbbVie Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 OncoMed Pharmaceuticals, Inc.
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Glenmark Pharmaceuticals Limited
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Xencor, Inc.
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Xencor, Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 MacroGenics, Inc.
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 MacroGenics, Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Aptevo Therapeutics Inc.
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Ligand Pharmaceuticals, Inc.
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Regeneron Pharmaceuticals, Inc.
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Double Barreled Antibodies Drug Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Fresenius SE & Co. KGaA
    10.12 Merus N.V.

11 Double Barreled Antibodies Drug Manufacturing Cost Analysis
    11.1 Double Barreled Antibodies Drug Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Double Barreled Antibodies Drug

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Double Barreled Antibodies Drug Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Double Barreled Antibodies Drug Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Double Barreled Antibodies Drug Market Forecast (2017-2022)
    15.1 Asia-Pacific Double Barreled Antibodies Drug Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Double Barreled Antibodies Drug Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Double Barreled Antibodies Drug Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Double Barreled Antibodies Drug Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Double Barreled Antibodies Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Double Barreled Antibodies Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Double Barreled Antibodies Drug Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Double Barreled Antibodies Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Double Barreled Antibodies Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Double Barreled Antibodies Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Double Barreled Antibodies Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Double Barreled Antibodies Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Double Barreled Antibodies Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Double Barreled Antibodies Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Double Barreled Antibodies Drug Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Double Barreled Antibodies Drug Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Double Barreled Antibodies Drug Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Double Barreled Antibodies Drug Price Forecast by Type (201